C., Awasthi, S
Dual regulation of transcription factor Nrf2 by Keap1 and by the combined actions of -TrCP and GSK-3
Hanaoka, K., Sasakura, K., Suwanai, Y., Toma-Fukai, S., Shimamoto, K., Takano, Y
Chronic kidney disease diagnosis and management: a review
If you're on a 1ml weekly protocol and seeing no measurable change after six weeks, the problem is almost never 'too low a dose.' It's either formulation quality (underdosed methionine or choline), dietary interference (you're in maintenance calories, not deficit), or liver saturation (you're already consuming high dietary methionine and adding more doesn't shift the pathway further)
Clinical data shows reductions in VAT beginning within 1 to 2 weeks, with substantial changes evident by 8 to 12 weeks of daily 2mg subcutaneous injections